Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Sparing Effect in Pediatric Dental TIVA
NCT03422978Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- Mar 2018
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, sponsored by University of British Columbia. Started Mar 2018; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT03422978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03422978.